Two researchers at Albert Einstein College of Medicine of Yeshiva University have found that our 98.6° F (37° C) body temperature strikes a perfect balance: warm enough to ward off fungal infection but not so hot that we need to eat nonstop to maintain our metabolism.
"One of the mysteries about humans and other advanced mammals has been why they are so hot compared with other animals," says study co-author Arturo Casadevall, MD, PhD, professor and chair of microbiology and immunology at Einstein. "This study helps to explain why mammalian temperatures are all around 37° C." Casadevall also holds the Leo and Julia Forchheimer Chair in Microbiology and Immunology.
The research builds upon earlier work by Casadevall showing that the number of fungal species that can thrive and therefore infect an animal declines by 6 percent for every 1° C rise in temperature. This means that tens of thousands of fungal species infect reptiles, amphibians and other coldblooded animals, but only a few hundred harm mammals. Such protection against fungal infection, Dr. Casadevall has speculated, could have been crucial for the triumph of mammals following the age of dinosaurs.
In this study, Casadevall and his Einstein coauthor, Aviv Bergman, PhD, professor and founding chair of systems and computational biology, devised a mathematical model that analyzed the benefits gained by body temperatures that protect against fungi versus the costs (in terms of extra food consumption) required to maintain body temperatures between 30° and 40° C. The optimal temperature for maximizing benefits while minimizing costs was found to be 36.7° C, which closely approximates normal body temperature.
"This study is a good example of how mammalian evolution has been driven by both external biological factors and internal physiological constraints," says Bergman.
The paper, "Mammalian Endothermy Optimally Restricts Fungi and Metabolic Costs," appeared in the Nov. 9 edition of mBio.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.